The presently-disclosed subject includes permanent-charge-bearing phenothiazinc derivatives that are redox-active, have beneficial solubility, and do not require supporting salts when used in redox flow battery applications.

The presently-disclosed subject includes permanent-charge-bearing phenothiazinc derivatives that are redox-active, have beneficial solubility, and do not require supporting salts when used in redox flow battery applications.

Compounds exhibiting high hole mobility and/or high glass transition temperatures are provided which are of the formula [Ar.sup.1].sub.m[Ar.sup.2].sub.n wherein: m is an integer from 1-3 and n is an integer and may be 1 or 2; Ar.sup.1 represents a thianthrene residue having a linkage to Ar.sup.2 at one or two positions selected from ring positions 1-4 and 5-8 and optionally mono-, bi- or poly-substituted with C.sub.1-C.sub.4-alkyl-, C.sub.1-C.sub.4-alkoxy-, fluoro, phenyl or biphenyl which in the case of phenyl or biphenyl may be further substituted with C.sub.1-C.sub.4-alkyl-, C.sub.1-C.sub.4-alkoxy- or fluoro; Ar.sup.2 represents a residue derived from an arylamine in which the aryl rings are phenyl, naphthyl or anthracenyl optionally substituted with C.sub.1-C.sub.4-alkyl-, C.sub.1-C.sub.4-alkoxy- or fluoro, a polycyclic fused or chain aromatic ring system optionally containing nitrogen or sulphur and in a chain aromatic ring system optionally containing one or more chain oxygen or sulphur atoms, a triarylphosphine oxide or an arylsilane the rings of any of which are optionally substituted with C.sub.1-C.sub.4-alkyl-, C.sub.1-C.sub.4-alkoxy- or fluoro.

Certain of the compounds may be used in electron transport layers and may be doped with p-type dopants. They may be incorporated into OLEDs, organic photovoltaic devices, imaging members and thin film transistors.

In further embodiments there are provided OLEDs or other devices e.g. electrostatic latent image forming members in which improved efficiency is obtained by using as electron transport layers, electron injectors, hosts and emitters (dopants) ambipolar or electron-transmitting compounds in which thianthrene is bonded to aryl e.g. 1-anthracenyl-9-yl-thianthrene, 1-biphenyl-4-yl-thianthrene and 9,10-Bis(1-thianthrenyl) anthracene.

The present specification provides an amine compound and an organic light emitting device including the same.

Compounds, compositions and method of using these compounds are disclosed for treating a disease or disorder in which it is desirable to inhibit BAX, such as a cardiovascular disease or disorder.

Compounds, compositions and method of using these compounds are disclosed for treating a disease or disorder in which it is desirable to inhibit BAX, such as a cardiovascular disease or disorder.

The invention relates to an organic molecule having a structure of the formula I

##STR00001##

where X=CN or CF.sub.3; D=chemical unit having a structure of the formula I-1:

##STR00002##

where #=attachment point of the unit of formula I-1 to the central phenyl ring in the structure of formula I; A and B=independently of one another selected from the group consisting of CRR.sup.1, CR, NR, N, there being a single or double bond between A and B and a single or double bond between B and Z; Z=a direct bond or a divalent organic bridge which is a substituted or unsubstituted C1-C9-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or arylene group or a combination thereof, CRR.sup.1, CCRR.sup.1, CNR, NR, O, SiRR.sup.1, S, S(O), S(O).sub.2, O-interrupted substituted or unsubstituted C1-C9-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or arylene group, phenyl units or substituted phenyl units.

The invention relates to an organic molecule having a structure of the formula I

##STR00001##

where X=CN or CF.sub.3; D=chemical unit having a structure of the formula I-1:

##STR00002##

where #=attachment point of the unit of formula I-1 to the central phenyl ring in the structure of formula I; A and B=independently of one another selected from the group consisting of CRR.sup.1, CR, NR, N, there being a single or double bond between A and B and a single or double bond between B and Z; Z=a direct bond or a divalent organic bridge which is a substituted or unsubstituted C1-C9-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or arylene group or a combination thereof, CRR.sup.1, CCRR.sup.1, CNR, NR, O, SiRR.sup.1, S, S(O), S(O).sub.2, O-interrupted substituted or unsubstituted C1-C9-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or arylene group, phenyl units or substituted phenyl units.

Tricyclic chemical modulators of protein phosphatase 2A are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity, stress-induced depression, inflammation, and acne. The compounds are of the following phenothiazine and dibenzoazepine compounds and similar genera: ##STR00001##

A compound and an organic optoelectronic device are provided. The compound has the following chemical formula (I): ##STR00001##
chemical formula (I). In the chemical formula (I), X.sub.1 to X.sub.2 are independently selected from O, S, ##STR00002##
and substituted or unsubstituted methylene, and a substituent is selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. X.sub.3 is selected from O, S, substituted or unsubstituted methylene, substituted or unsubstituted methylene, and substituted or unsubstituted silylene, and a substituent is selected hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. R.sub.1 to R.sub.17 are independently selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl.